Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Submission Forms
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
Place an ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Krystal Biotech Inc
(NQ:
KRYS
)
59.04
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
59.04
Bid (Size)
5.000 (1)
Ask (Size)
75.00 (1)
Prev. Close
59.04
Today's Range
59.04 - 59.04
52wk Range
38.86 - 102.99
Shares Outstanding
22,205,642
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Krystal Biotech Stock Sees Healthy Relative Strength Rating Upgrade
April 14, 2022
On Thursday, Krystal Biotech stock had its Relative Strength (RS) Rating upgraded from to 93, up 88 a day ago.
Via
Investor's Business Daily
Recap: Krystal Biotech Q4 Earnings
February 28, 2022
Krystal Biotech (NASDAQ:KRYS) reported its Q4 earnings results on Monday, February 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Performance
YTD
-18.13%
-18.13%
1 Month
-14.82%
-14.82%
3 Month
-3.36%
-3.36%
6 Month
+40.14%
+40.14%
1 Year
-10.15%
-10.15%
More News
Read More
BofA Bullish On This Gene Therapy Biotech Transitioning Into A Commercial Enterprise
January 18, 2022
Via
Benzinga
Why Krystal Biotech's Shares Rose More Than 77% This Week
December 02, 2021
Via
The Motley Fool
Why Krystal Biotech Stock Is Retreating Today
December 01, 2021
Via
The Motley Fool
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
Via
Benzinga
50 Biggest Movers From Yesterday
November 30, 2021
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 29, 2021
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 300 Points; Krystal Biotech Shares Spike Higher
November 29, 2021
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
November 29, 2021
Via
Benzinga
Stocks Rise as "Fear Gauge" Cools Off
November 29, 2021
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Crude Oil Rises 4%; Fennec Pharmaceuticals Shares Slide
November 29, 2021
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
33 Stocks Moving In Monday's Mid-Day Session
November 29, 2021
Via
Benzinga
KRYS Stock Alert: The Study Results That Have Krystal Biotech Rocketing 118% Today
November 29, 2021
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Higher; Li Auto Sales Top Views
November 29, 2021
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 29, 2021
Via
Benzinga
Krystal Biotech Shares More Than Double During Premarket Monday: What Investors Need To Know
November 29, 2021
Via
Benzinga
61 Biggest Movers From Yesterday
November 23, 2021
Via
Benzinga
Exposures
Product Safety
40 Stocks Moving In Monday's Mid-Day Session
November 22, 2021
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
July 20, 2021
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
July 20, 2021
Via
Benzinga
Krystal Biotech's KB105 Shows Detectable, Functionally Active TGM-1 Enzyme In Genetic Skin Condition
July 02, 2021
Via
Benzinga
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
July 02, 2021
Via
Benzinga
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
June 27, 2021
Via
Benzinga
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.